MA24854A1 - NITRIC OXIDE SYNTHASE INHIBITORS - Google Patents
NITRIC OXIDE SYNTHASE INHIBITORSInfo
- Publication number
- MA24854A1 MA24854A1 MA25569A MA25569A MA24854A1 MA 24854 A1 MA24854 A1 MA 24854A1 MA 25569 A MA25569 A MA 25569A MA 25569 A MA25569 A MA 25569A MA 24854 A1 MA24854 A1 MA 24854A1
- Authority
- MA
- Morocco
- Prior art keywords
- nitric oxide
- oxide synthase
- synthase inhibitors
- inhibitors
- nitric
- Prior art date
Links
- 239000000236 nitric oxide synthase inhibitor Substances 0.000 title 1
- CSYSULGPHGCBQD-UHFFFAOYSA-N s-ethylisothiouronium diethylphosphate Chemical compound CCSC(N)=N.CCOP(O)(=O)OCC CSYSULGPHGCBQD-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9810299.9A GB9810299D0 (en) | 1998-05-15 | 1998-05-15 | Use of nitric oxide synthase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
MA24854A1 true MA24854A1 (en) | 1999-12-31 |
Family
ID=10832007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25569A MA24854A1 (en) | 1998-05-15 | 1999-05-05 | NITRIC OXIDE SYNTHASE INHIBITORS |
Country Status (6)
Country | Link |
---|---|
AR (1) | AR020587A1 (en) |
AU (1) | AU4040699A (en) |
GB (1) | GB9810299D0 (en) |
MA (1) | MA24854A1 (en) |
PE (1) | PE20000474A1 (en) |
WO (1) | WO1999059566A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0031179D0 (en) * | 2000-12-21 | 2001-01-31 | Glaxo Group Ltd | Nitric oxide synthase inhibitors |
BR0310061A (en) * | 2002-05-16 | 2005-03-01 | Pharmacia Corp | Methods for treating respiratory diseases and conditions with a selective inhibitor of inos and a inhibitor of pde and their compositions |
US8524734B2 (en) | 2005-05-18 | 2013-09-03 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
US7838532B2 (en) | 2005-05-18 | 2010-11-23 | Mpex Pharmaceuticals, Inc. | Aerosolized fluoroquinolones and uses thereof |
JP2012505223A (en) | 2008-10-07 | 2012-03-01 | エムペックス・ファーマシューティカルズ・インコーポレーテッド | Aerosol fluoroquinolone formulation for improved pharmacokinetics |
ES2809177T3 (en) | 2008-10-07 | 2021-03-03 | Horizon Orphan Llc | Inhalation of levofloxacin to reduce lung inflammation |
CA2773033C (en) | 2009-09-04 | 2016-10-11 | Mpex Pharmaceuticals, Inc. | Use of aerosolized levofloxacin for treating cystic fibrosis |
DE102010055322A1 (en) * | 2010-12-21 | 2012-06-21 | Christian-Albrechts-Universität Zu Kiel | Antibacterial and antifungal substances |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312835A (en) * | 1989-09-13 | 1994-05-17 | Board Of Regents, The University Of Texas System | Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension |
US5545625A (en) * | 1994-12-12 | 1996-08-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction |
GB9425701D0 (en) * | 1994-12-20 | 1995-02-22 | Wellcome Found | Enzyme inhibitors |
MY117948A (en) * | 1997-01-13 | 2004-08-30 | Glaxo Group Ltd | Nitride oxide synthase inhibitors. |
GB9702312D0 (en) * | 1997-02-05 | 1997-03-26 | Univ London | Method for identifying selective inhibitors of nitric oxide synthase |
-
1998
- 1998-05-15 GB GBGB9810299.9A patent/GB9810299D0/en not_active Ceased
-
1999
- 1999-05-05 MA MA25569A patent/MA24854A1/en unknown
- 1999-05-12 WO PCT/EP1999/003265 patent/WO1999059566A1/en active Application Filing
- 1999-05-12 PE PE1999000395A patent/PE20000474A1/en not_active Application Discontinuation
- 1999-05-12 AU AU40406/99A patent/AU4040699A/en not_active Abandoned
- 1999-05-12 AR ARP990102245A patent/AR020587A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU4040699A (en) | 1999-12-06 |
WO1999059566A1 (en) | 1999-11-25 |
GB9810299D0 (en) | 1998-07-15 |
AR020587A1 (en) | 2002-05-22 |
PE20000474A1 (en) | 2000-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE04013B1 (en) | Nitric oxide synthase inhibitors | |
NO20006044L (en) | Nitric oxide synthase inhibitors | |
NO20032753D0 (en) | Compound and Use thereof | |
NO20011293D0 (en) | Factor VIIa inhibitors | |
DE69927945D1 (en) | ELECTROMECHANIC PROTECTION | |
EE200000519A (en) | Halogenated amidino amino acid derivatives function as nitric oxide synthase inhibitors | |
DE69922454D1 (en) | record player | |
ID23780A (en) | NITRIC OXIDER INHIBITING PHINOVIRUS INFECTION | |
ATE252547T1 (en) | MATRIXMETALLOPROTEINASE INHIBITORS | |
MA24854A1 (en) | NITRIC OXIDE SYNTHASE INHIBITORS | |
NO985357D0 (en) | Methods for increasing nitric oxide synthesis | |
IS5236A (en) | Amidine derivatives which inhibit nitric oxide synthase | |
MA24877A1 (en) | PROTECTIVE INHIBITORS | |
DE69919423D1 (en) | reel furnace | |
MA25517A1 (en) | INSERTION TOOL | |
IT1308418B1 (en) | TIGHTENING SPINDLE | |
HRP980381B1 (en) | Nitric oxide synthase inhibitors | |
SI1084104T1 (en) | Nitric oxide synthase inhibitors | |
SI0958277T1 (en) | Nitric oxide synthase inhibitors | |
GB9303221D0 (en) | Nitric oxide synthase inhibitors | |
GB9315159D0 (en) | Nitric oxide synthase inhibitors | |
SE9802118D0 (en) | Mycobacterial inhibitors | |
FI3876U1 (en) | Steel abrasive tape | |
GB9827817D0 (en) | Type 11 Dehydroquinase inhibitors | |
SE9802633D0 (en) | Cassette Heat |